• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • WCW HOME
  • Submit a Wire!
  • Advertising
  • Media Partners
  • About
  • Contact Us

WorkCompWire

Your Trusted Source for Workers Compensation News

Enlyte
  • Workers Compensation News
    • Workers Compensation Industry News
    • Association, Rating & Research News
    • Claims, Legal, & Compliance News
    • Legislative & Regulatory News
    • Risk Management News
    • Work Force & Human Resource News
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • People On The Move

Enlyte Releases Part Two of Mitchell Pharmacy Solutions Drug Trends Series Report

June 3, 2022 - WorkCompWire

San Diego, CA – Enlyte recently released the second portion of its Mitchell Pharmacy Solutions Drug Trends Series Report, which analyzes the state of pharmacy trends in workers’ comp.

In part two of the series, Mitchell explores trends experienced within its combined in- and out-of-network channels to address the total view of prescription activity.

From a percentage perspective, in-network still represents the majority with over 80% of the prescriptions filled, with out-of-network representing less than 20%, indicating pharmacy management programs continue to positively influence prescription utilization.

Key highlights included:

  • Both out-of-network prescription utilization and cost decreased slightly from 2020 (down 1.2 & 1.4 points respectively)
  • Generic utilization remained relatively flat at 88.1% from 88.3% of all prescriptions in 2020. Generic efficiency increased 0.1 points from 98.2% to 98.3%.
  • The top 10 therapeutic classes accounted for a majority of both total scripts and total cost.
  • Seven of the top 10 therapeutic classes experienced decreased utilization and cost per claim in 2021.
  • The largest utilization increase was within the hematological class at 3.8%, and the largest decrease was within the antiulcer class at 13.8%, followed by the opioid class at 10.2%.

Get the free report: Mitchell Pharmacy Solutions Drug Trends Series Part 2

Source: Enlyte

Disclosure:
Enlyte is a WorkCompWire ad partner.
This is NOT a paid placement.

Filed Under: Association, Rating & Research News, Industry News, Top Stories, Workers' Compensation

Primary Sidebar

Get Our Free Newsletter:

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: WorkCompWire.com, PO Box 1114, Culver City, CA, 90232, http://www.workcompwire.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

myMatrixx

Paradigm

MSQ

Follow Us on Twitter

Tweets by WorkCompWire

Workers Compensation News Topics

  • Top Stories
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • The RxProfessor
  • Industry News
  • Association, Rating & Research News
  • People On The Move
  • Claims, Legal, & Compliance News
  • Legislative & Regulatory News
  • Risk Management News
  • Work Force & Human Resource News
  • Workers’ Compensation

Wire Archives

Copyright WorkCompWire © 2023